These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 35005630)

  • 1. Dysregulation of mitochondrial and proteolysosomal genes in Parkinson's disease myeloid cells.
    Navarro E; Udine E; Lopes KP; Parks M; Riboldi G; Schilder BM; Humphrey J; Snijders GJL; Vialle RA; Zhuang M; Sikder T; Argyrou C; Allan A; Chao MJ; Farrell K; Henderson B; Simon S; Raymond D; Elango S; Ortega RA; Shanker V; Swan M; Zhu CW; Ramdhani R; Walker RH; Tse W; Sano M; Pereira AC; Ahfeldt T; Goate AM; Bressman S; Crary JF; de Witte L; Frucht S; Saunders-Pullman R; Raj T
    Nat Aging; 2021 Sep; 1(9):850-863. PubMed ID: 35005630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A monocyte gene expression signature in the early clinical course of Parkinson's disease.
    Schlachetzki JCM; Prots I; Tao J; Chun HB; Saijo K; Gosselin D; Winner B; Glass CK; Winkler J
    Sci Rep; 2018 Jul; 8(1):10757. PubMed ID: 30018301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptome deregulation of peripheral monocytes and whole blood in GBA-related Parkinson's disease.
    Riboldi GM; Vialle RA; Navarro E; Udine E; de Paiva Lopes K; Humphrey J; Allan A; Parks M; Henderson B; Astudillo K; Argyrou C; Zhuang M; Sikder T; Oriol Narcis J; Kumar SD; Janssen W; Sowa A; Comi GP; Di Fonzo A; Crary JF; Frucht SJ; Raj T
    Mol Neurodegener; 2022 Aug; 17(1):52. PubMed ID: 35978378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered Transcriptional Profile of Mitochondrial DNA-Encoded OXPHOS Subunits, Mitochondria Quality Control Genes, and Intracellular ATP Levels in Blood Samples of Patients with Parkinson's Disease.
    Gezen-Ak D; Alaylıoğlu M; Genç G; Şengül B; Keskin E; Sordu P; Güleç ZEK; Apaydın H; Bayram-Gürel Ç; Ulutin T; Yılmazer S; Ertan S; Dursun E
    J Alzheimers Dis; 2020; 74(1):287-307. PubMed ID: 32007957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The interplay between monocytes, α-synuclein and LRRK2 in Parkinson's disease.
    Strader S; West AB
    Biochem Soc Trans; 2023 Apr; 51(2):747-758. PubMed ID: 37013975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptomic profiles in Parkinson's disease.
    Kurvits L; Lättekivi F; Reimann E; Kadastik-Eerme L; Kasterpalu KM; Kõks S; Taba P; Planken A
    Exp Biol Med (Maywood); 2021 Mar; 246(5):584-595. PubMed ID: 33148011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptomic signatures of brain regional vulnerability to Parkinson's disease.
    Keo A; Mahfouz A; Ingrassia AMT; Meneboo JP; Villenet C; Mutez E; Comptdaer T; Lelieveldt BPF; Figeac M; Chartier-Harlin MC; van de Berg WDJ; van Hilten JJ; Reinders MJT
    Commun Biol; 2020 Mar; 3(1):101. PubMed ID: 32139796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptomic Profiling of Circular RNA in Different Brain Regions of Parkinson's Disease in a Mouse Model.
    Jia E; Zhou Y; Liu Z; Wang L; Ouyang T; Pan M; Bai Y; Ge Q
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32344560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Microglia differential genes and their functions in paraquat-induced Parkinson's disease-like in mice's brains based on single-cell RNA sequencing].
    Guo ZK; Zhang YT; Zhang Y; Weng YL; Li HY; Wu SY
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2024 Apr; 42(4):248-257. PubMed ID: 38677987
    [No Abstract]   [Full Text] [Related]  

  • 10. Transcriptome analysis reveals link between proteasomal and mitochondrial pathways in Parkinson's disease.
    Duke DC; Moran LB; Kalaitzakis ME; Deprez M; Dexter DT; Pearce RK; Graeber MB
    Neurogenetics; 2006 Jul; 7(3):139-48. PubMed ID: 16699787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain transcriptomic profiling in idiopathic and LRRK2-associated Parkinson's disease.
    Botta-Orfila T; Sànchez-Pla A; Fernández M; Carmona F; Ezquerra M; Tolosa E
    Brain Res; 2012 Jul; 1466():152-7. PubMed ID: 22634372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crohn's and Parkinson's Disease-Associated LRRK2 Mutations Alter Type II Interferon Responses in Human CD14
    Ikezu T; Koro L; Wolozin B; Farraye FA; Strongosky AJ; Wszolek ZK
    J Neuroimmune Pharmacol; 2020 Dec; 15(4):794-800. PubMed ID: 32180132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated alpha-synuclein impairs innate immune cell function and provides a potential peripheral biomarker for Parkinson's disease.
    Gardai SJ; Mao W; Schüle B; Babcock M; Schoebel S; Lorenzana C; Alexander J; Kim S; Glick H; Hilton K; Fitzgerald JK; Buttini M; Chiou SS; McConlogue L; Anderson JP; Schenk DB; Bard F; Langston JW; Yednock T; Johnston JA
    PLoS One; 2013; 8(8):e71634. PubMed ID: 24058406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prefrontal Cortex Transcriptomic Deconvolution Implicates Monocyte Infiltration in Parkinson's Disease.
    Batchu S
    Neurodegener Dis; 2020; 20(2-3):110-112. PubMed ID: 32980850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptomic profiling of differentially expressed genes and related pathways in different brain regions in Parkinson's disease.
    Jia E; Pan M; Liu Z; Zhou Y; Zhao X; Dong J; Bai Y; Ge Q
    Neurosci Lett; 2020 Jul; 732():135074. PubMed ID: 32446776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multimodal analysis of gene expression from postmortem brains and blood identifies synaptic vesicle trafficking genes to be associated with Parkinson's disease.
    Gao X; Huang Z; Feng C; Guan C; Li R; Xie H; Chen J; Li M; Que R; Deng B; Cao P; Li M; Lu J; Huang Y; Li M; Yang W; Yang X; Wen C; Liang X; Yang Q; Chao YX; Chan LL; Yenari MA; Jin K; Chaudhuri KR; Zhang J; Tan EK; Wang Q
    Brief Bioinform; 2021 Jul; 22(4):. PubMed ID: 33079984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of altered molecular mechanisms in Parkinson's disease through cell type-resolved multiomics analyses.
    Lee AJ; Kim C; Park S; Joo J; Choi B; Yang D; Jun K; Eom J; Lee SJ; Chung SJ; Rissman RA; Chung J; Masliah E; Jung I
    Sci Adv; 2023 Apr; 9(15):eabo2467. PubMed ID: 37058563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of the immune system, endocytosis and EIF2 signaling in both genetically determined and sporadic forms of Parkinson's disease.
    Mutez E; Nkiliza A; Belarbi K; de Broucker A; Vanbesien-Mailliot C; Bleuse S; Duflot A; Comptdaer T; Semaille P; Blervaque R; Hot D; Leprêtre F; Figeac M; Destée A; Chartier-Harlin MC
    Neurobiol Dis; 2014 Mar; 63():165-70. PubMed ID: 24269915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-cell autonomous mechanism of Parkinson's disease pathology caused by G2019S LRRK2 mutation in Ashkenazi Jewish patient: Single cell analysis.
    Kim J; Daadi MM
    Brain Res; 2019 Nov; 1722():146342. PubMed ID: 31330122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Looking beyond the brain to improve the pathogenic understanding of Parkinson's disease: implications of whole transcriptome profiling of Patients' skin.
    Planken A; Kurvits L; Reimann E; Kadastik-Eerme L; Kingo K; Kõks S; Taba P
    BMC Neurol; 2017 Jan; 17(1):6. PubMed ID: 28068941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.